<VariationArchive VariationID="1324881" VariationName="NM_002618.4(PEX13):c.107_120del (p.Gly36fs)" VariationType="Deletion" Accession="VCV001324881" Version="4" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-03-17" DateCreated="2021-11-29" MostRecentSubmission="2024-02-04">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1315145" VariationID="1324881">
      <GeneList>
        <Gene Symbol="PEX13" FullName="peroxisomal biogenesis factor 13" GeneID="5194" HGNC_ID="HGNC:8855" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2p15</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="61017720" stop="61051990" display_start="61017720" display_stop="61051990" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="61244811" stop="61279124" display_start="61244811" display_stop="61279124" Strand="+" />
          </Location>
          <OMIM>601789</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_002618.4(PEX13):c.107_120del (p.Gly36fs)</Name>
      <CanonicalSPDI>NC_000002.12:61031431:GGTCCTACTTTAATG:G</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2p15</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="61031432" stop="61031445" display_start="61031432" display_stop="61031445" variantLength="14" positionVCF="61031431" referenceAlleleVCF="GGGTCCTACTTTAAT" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="61258567" stop="61258580" display_start="61258567" display_stop="61258580" variantLength="14" positionVCF="61258566" referenceAlleleVCF="GGGTCCTACTTTAAT" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>G36fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.61258568_61258581del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.61258568_61258581del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.61031433_61031446del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.61031433_61031446del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008665.1" sequenceAccession="NG_008665" sequenceVersion="1" change="g.18757_18770del">
            <Expression>NG_008665.1:g.18757_18770del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002618.4" sequenceAccession="NM_002618" sequenceVersion="4" change="c.107_120del" MANESelect="true">
            <Expression>NM_002618.4:c.107_120del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_002609.1" sequenceAccession="NP_002609" sequenceVersion="1" change="p.Gly36fs">
            <Expression>NP_002609.1:p.Gly36fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="601789.0004" DB="OMIM" />
        <XRef Type="rs" ID="2104803129" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_002618.4(PEX13):c.107_120del (p.Gly36fs) AND not provided" Accession="RCV001782601" Version="4">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-02-08" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_002618.4(PEX13):c.107_120del (p.Gly36fs) AND Peroxisome biogenesis disorder 11A (Zellweger)" Accession="RCV002293256" Version="1">
        <ClassifiedConditionList TraitSetID="8966">
          <ClassifiedCondition DB="MedGen" ID="C3554000">Peroxisome biogenesis disorder 11A (Zellweger)</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2009-06-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-02-08" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2021-11-29" MostRecentSubmission="2024-02-04">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">19449432</ID>
        </Citation>
        <DescriptionHistory Dated="2023-03-07">
          <Description>Pathogenic/Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-10-26">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-10-26">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="8966" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="17442" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Peroxisome biogenesis disorder 11A (Zellweger)</ElementValue>
                <XRef ID="MONDO:0013949" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Peroxisome biogenesis disorder 11A</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PBD11A</ElementValue>
                <XRef ID="GTR000522759" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="614883" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15874" />
                <XRef ID="15874" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Zellweger syndrome (ZS) is an autosomal recessive multiple congenital anomaly syndrome resulting from disordered peroxisome biogenesis. Affected children present in the newborn period with profound hypotonia, seizures, and inability to feed. Characteristic craniofacial anomalies, eye abnormalities, neuronal migration defects, hepatomegaly, and chondrodysplasia punctata are present. Children with this condition do not show any significant development and usually die in the first year of life (summary by Steinberg et al., 2006).
For a complete phenotypic description and a discussion of genetic heterogeneity of Zellweger syndrome, see 214100.
Individuals with PBDs of complementation group 13 (CG13, equivalent to CGH) have mutations in the PEX13 gene. For information on the history of PBD complementation groups, see 214100.</Attribute>
                <XRef Type="MIM" ID="614883" DB="OMIM" />
              </AttributeSet>
              <XRef ID="912" DB="Orphanet" />
              <XRef ID="C3554000" DB="MedGen" />
              <XRef ID="MONDO:0013949" DB="MONDO" />
              <XRef Type="MIM" ID="614883" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="49698" SubmissionDate="2017-01-25" DateLastUpdated="2017-01-30" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="601789.0004_PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)" title="PEX13, 14-BP DEL, EXON 2_PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)" />
        <ClinVarAccession Accession="SCV000044442" DateUpdated="2017-01-30" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2009-06-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a Saudi boy, born of consanguineous parents, with Zellweger syndrome (PBD11A; 614883), Al-Dirbashi et al. (2009) identified a homozygous 14-bp deletion in exon 2 of the PEX13 gene, resulting in a frameshift and premature termination. The patient was admitted to the neonatal intensive care unit shortly after birth because of severe hypotonia, where he showed recurrent apnea, seizures, and elevated liver enzymes. Renal ultrasound showed multiple cysts. He had dysmorphic facies with anteverted nostrils, a depressed nasal bridge, and a large, triangular face. At age 6 months, he showed severe failure to thrive, progressive hepatic dysfunction, and global developmental delay. Fibroblast peroxisomes showed a classic 'ghost' appearance due to abnormal protein import, and complementation studies indicated complementation group H (group 13). The deletion was predicted to result in complete loss of PEX13 function.</Attribute>
              <Citation>
                <ID Source="PubMed">19449432</ID>
              </Citation>
              <XRef DB="OMIM" ID="614883" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PEX13" />
          </GeneList>
          <Name>PEX13, 14-BP DEL, EXON 2</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">14-BP DEL, EXON 2</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="601789.0004" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3960493" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="1c30aedc3912ab5812e2dc78d6ebad1f06e6e92dd872552d7fc8c81b1e2ee413|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002021668" DateUpdated="2024-02-04" DateCreated="2021-11-29" Type="SCV" Version="3" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-02-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_002618.3:c.107_120del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10694847</SubmissionName>
          <SubmissionName>SUB12926214</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="49698" TraitType="Disease" MappingType="Name" MappingValue="PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)" MappingRef="Preferred">
        <MedGen CUI="C3554000" Name="Peroxisome biogenesis disorder 11A (Zellweger)" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3960493" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

